Your browser doesn't support javascript.
loading
Clinically relevant doses of candesartan inhibit growth of prostate tumor xenografts in vivo through modulation of tumor angiogenesis.
Alhusban, Ahmed; Al-Azayzih, Ahmad; Goc, Anna; Gao, Fei; Fagan, Susan C; Somanath, Payaningal R.
Afiliação
  • Alhusban A; Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy and the Charlie Norwood VA Medical Center, Augusta, Georgia (A.A., A.A.-A., A.G., F.G., S.C.F., P.R.S.); Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan (A.A.); and Department
  • Al-Azayzih A; Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy and the Charlie Norwood VA Medical Center, Augusta, Georgia (A.A., A.A.-A., A.G., F.G., S.C.F., P.R.S.); Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan (A.A.); and Department
  • Goc A; Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy and the Charlie Norwood VA Medical Center, Augusta, Georgia (A.A., A.A.-A., A.G., F.G., S.C.F., P.R.S.); Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan (A.A.); and Department
  • Gao F; Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy and the Charlie Norwood VA Medical Center, Augusta, Georgia (A.A., A.A.-A., A.G., F.G., S.C.F., P.R.S.); Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan (A.A.); and Department
  • Fagan SC; Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy and the Charlie Norwood VA Medical Center, Augusta, Georgia (A.A., A.A.-A., A.G., F.G., S.C.F., P.R.S.); Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan (A.A.); and Department
  • Somanath PR; Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy and the Charlie Norwood VA Medical Center, Augusta, Georgia (A.A., A.A.-A., A.G., F.G., S.C.F., P.R.S.); Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan (A.A.); and Department
J Pharmacol Exp Ther ; 350(3): 635-45, 2014 Sep.
Article em En | MEDLINE | ID: mdl-24990940
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Tetrazóis / Benzimidazóis / Inibidores da Angiogênese / Ensaios Antitumorais Modelo de Xenoenxerto / Neovascularização Patológica Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: J Pharmacol Exp Ther Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Tetrazóis / Benzimidazóis / Inibidores da Angiogênese / Ensaios Antitumorais Modelo de Xenoenxerto / Neovascularização Patológica Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: J Pharmacol Exp Ther Ano de publicação: 2014 Tipo de documento: Article